| Business Summary | | Rockwell
Medical
Technologies,
Inc.
(Rockwell)
provides
products
used
in
the
treatment
of
patients
with
end-stage
renal
disease.
Rockwell
manufactures
hemodialysis
concentrates
and
dialysis
kits,
and
sells,
distributes
and
delivers
such
concentrates
and
dialysis
kits,
as
well
as
other
ancillary
hemodialysis
products,
to
hemodialysis
providers
in
the
United
States.
Hemodialysis
is
a
process
that
duplicates
kidney
functions
in
patients
whose
kidneys
have
failed
to
function
properly.
The
Company
has
positioned
itself
as
an
independent
"one-stop-shop"
to
its
customers
for
the
concentrates,
chemicals
and
supplies
necessary
to
support
a
hemodialysis
provider's
operation. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Rockwell
Medical
Technologies,
Inc.
manufactures,
sells,
distributes,
and
delivers
hemodialysis
concentrates,
dialysis
kits,
and
other
hemodialysis
products
to
hemodialysis
providers
in
the
United
States
and
Venezuela.
For
the
six
months
ended
6/30/01,
revenues
rose
33%
to
$4.4
million.
Net
loss
rose
9%
to
$641
thousand.
Results
reflect
increased
sales
of
the
Dri-Sate
Dry
Acid
Concentrate
product
line,
offset
by
additional
costs
for
new
production
facilities. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Robert Chioini, 36 Chairman,
Pres, CEO | $295K | Thomas Klema, 47 CFO,
VP-Fin., Treasurer, Sec. | 153K | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|